rf-fullcolor.png

 

June 30, 2017
by Zachary Brennan

2016 CMS Data on Industry Payments to US Physicians, Hospitals: Company Breakdowns

The US Centers for Medicare and Medicaid Services (CMS) on Friday released 2016 data on more than $8 billion in payments (which is on par with 2015 data) made by 1,481 pharmaceutical, biotech and medical device companies to more than 600,000 physicians and 1,146 hospitals.

In total, CMS calculated that $2.8 billion was spent on general payments and $4.36 billion on research payments. 

In its breakdown of the numbers, CMS says that more than $1 billion in 2016 was spent on physicians for speaking, training and education engagements that are not for continuing education, and on royalties or other payments based on sales of products that use a physician’s intellectual property.

And more than $430 million in 2016 was spent on food, beverages, travel and lodging, which compares to about $440 million in 2015.

The database also breaks down the figures by company, though some of the multinational biopharmaceutical companies, like Roche and Johnson & Johnson, did not disclose complete numbers that matched their peers for 2016. The following is a breakdown of what was listed for some of the largest companies (in alphabetical order):

General and Research Payments by Companies (values in millions USD)
Company General Payments (2016)Research Payments (2016)General Payments (2015)Research Payments (2015)
AbbVie $34.9$136$39.9$121.3
Allergan $66.4$82.3$35.9$28.2
Amgen $35.3$182.4$31.9$332.2
AstraZeneca$43.7$226.6$54.5$232.7
Bayer Pharmaceuticals $11$28$11.5$23.1
Celgene$54.6$49.8$38.1$44.2
Gilead Sciences$43.4$59.4$37$71.7
GlaxoSmithKline$30.5$94$36$108.2
Merck Sharpe & Dohme$39.8$261.9$34.9$129.2
Novartis$34.9$436.6$27.6$550
Pfizer, Inc.$45.9$429.1$45.4$392.9
Regeneron Pharmaceuticals$14.7$64$8.9$46.8
Valeant Pharmaceuticals$50.3$5.4$29.1$4.3
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.